Home › Funds › Parkman Healthcare Partners LLC › LIVN

Parkman Healthcare Partners LLC position in LIVN

LIVANOVA PLC · Health Care

Parkman Healthcare Partners LLC reported holding 195,564 shares of LIVN (LIVANOVA PLC) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 1.35% of its reported portfolio and ranking #26 among its reported holdings. Parkman Healthcare Partners LLC has disclosed LIVN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)195.56K sh
Reported value held$14.96M
Portfolio Weight1.35%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's LIVN position evolved

Parkman Healthcare Partners LLC first disclosed a stake in LIVN in Q1 2024 at 145,000 shares (US$8.1M). The position peaked in Q1 2026 at 403,965 shares, worth US$25.7M. Across 11 filings, Parkman Healthcare Partners LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 195,564 shares valued at US$15.0M — a reduction of -14,965 shares quarter over quarter.. Notable position changes include a 72% increase in Q4 2024 (shares fell 15% over the following quarter), a 58% increase in Q3 2025 (shares rose 17% over the following quarter), a 49% increase in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 145.00K $8.11M New
Q2 2024 85.16K $4.67M Reduce
Q3 2024 101.73K $5.34M Add
Q4 2024 174.93K $8.10M Add
Q1 2025 166.87K $6.55M Reduce
Q2 2025 175.00K $7.88M Add
Q3 2025 275.81K $14.45M Add
Q4 2025 410.91K $25.28M Add
Q1 2026 403.96K $25.68M Reduce
Q2 2026 210.53K $17.31M Reduce
Q3 2026 195.56K $14.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LIVN and 13F data

LIVN (LIVANOVA PLC) is a Health Care company. 33 other funds we track also report a position in LIVN — the largest reported positions include Hood River Capital Management LLC (US$196.5M), CONGRESS ASSET MANAGEMENT CO (US$115.0M), Greenhouse Funds LLLP (US$69.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LIVN

All LIVN fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held LIVN?

Parkman Healthcare Partners LLC has disclosed LIVN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Parkman Healthcare Partners LLC's current position in LIVN?

As of Q3 2026, Parkman Healthcare Partners LLC holds 195.56K shares of LIVN (LIVANOVA PLC), valued at $14.96M, representing 1.35% of its reported portfolio and ranking #26.

Has Parkman Healthcare Partners LLC been buying or selling LIVN?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in LIVN. The position peaked in Q1 2026 at 403.96K shares.

Which other funds hold LIVN?

Other major institutional holders of LIVN include Hood River Capital Management LLC, CONGRESS ASSET MANAGEMENT CO, Greenhouse Funds LLLP, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.